Regeneron announces investor call and webcast at esmo 2022

Tarrytown, n.y. , sept. 9, 2022 /prnewswire/ -- regeneron pharmaceuticals, inc. (nasdaq: regn) will host a conference call and simultaneous webcast to share updates on the company's oncology portfolio in conjunction with the european society for medical oncology (esmo) annual congress on monday, september 12, 2022.
REGN Ratings Summary
REGN Quant Ranking